Small-Cap Healthcare Comparison: BrainsWay vs. CapsoVision, Inc.
1 report, 1 independent
Updated Oct 10
AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both BrainsWay and CapsoVision, Inc. are classified as small-cap healthcare companies. A comparison of the two firms showed that BrainsWay has higher revenue and earnings than CapsoVision, Inc. CapsoVision, Inc. is currently trading at a lower price-to-earnings ratio than BrainsWay.
From tickerreport.com
Why it matters
Analysts favor BrainsWay due to its stronger consensus rating and higher probable upside, which is cited at 54.63% compared to CapsoVision, Inc.'s 44.16% upside. CapsoVision, Inc. is noted as being less volatile than the S&P 500 with a beta of -2.45, while BrainsWay has a beta of 1.29.
From tickerreport.com